Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept study. uri icon

authors

  • Nirogi, Ramakrishna
  • Dogiparti, Dhanunjay Kumar
  • Jasti, Venkat
  • Atri, Alireza
  • Cummings, Jeffrey
  • Ieni, John
  • Goyal, Vinod Kumar
  • Ravula, Jyothsna
  • Jetta, Satish
  • Shinde, Anil
  • Jayarajan, Pradeep
  • Benade, Vijay
  • Palacharla, Veera Raghava Chowdary

publication date

  • January 1, 2022